Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Application
  • Print
  • Share
  • E-mail
-

NDC Search Results on Active Ingredient: bosentan

Click on Active Ingredient to view the label.

Ingredient Name NDC Company Name Application Number or Regulatory Citation Product Type Marketing Category
BOSENTAN 68382-447-01  Zydus Pharmaceuticals USA Inc.  ANDA207760  HUMAN PRESCRIPTION DRUG  ANDA 
BOSENTAN 0591-2512-60  Actavis Pharma, Inc.  ANDA207110  HUMAN PRESCRIPTION DRUG  ANDA 
BOSENTAN 70771-1017-1  Zydus Lifesciences Limited  ANDA207760  HUMAN PRESCRIPTION DRUG  ANDA 
BOSENTAN 68382-446-28  Zydus Pharmaceuticals USA Inc.  ANDA207760  HUMAN PRESCRIPTION DRUG  ANDA 
BOSENTAN 66215-103-14  Actelion Pharmaceuticals US, Inc.  NDA209279  HUMAN PRESCRIPTION DRUG  NDA 
BOSENTAN 66215-232-14  Actelion Pharmaceuticals US, Inc.  NDA209279  HUMAN PRESCRIPTION DRUG  NDA 
BOSENTAN 66215-101-06  Actelion Pharmaceuticals US, Inc.  NDA021290  HUMAN PRESCRIPTION DRUG  NDA 
BOSENTAN 66215-232-56  Actelion Pharmaceuticals US, Inc.  NDA209279  HUMAN PRESCRIPTION DRUG  NDA 
BOSENTAN 66215-102-03  Actelion Pharmaceuticals US, Inc.  NDA021290  HUMAN PRESCRIPTION DRUG  NDA 
BOSENTAN 66215-103-56  Actelion Pharmaceuticals US, Inc.  NDA209279  HUMAN PRESCRIPTION DRUG  NDA 
BOSENTAN 66215-102-06  Actelion Pharmaceuticals US, Inc.  NDA021290  HUMAN PRESCRIPTION DRUG  NDA 
BOSENTAN 66215-101-03  Actelion Pharmaceuticals US, Inc.  NDA021290  HUMAN PRESCRIPTION DRUG  NDA 
1-30 31-42

Return to the FDA Label Search Page
-
-